Compare WAT & CBOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WAT | CBOE |
|---|---|---|
| Founded | 1958 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Investment Bankers/Brokers/Service |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.2B | 34.2B |
| IPO Year | 1996 | 2010 |
| Metric | WAT | CBOE |
|---|---|---|
| Price | $473.89 | $370.11 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 24 | 18 |
| Target Price | ★ $503.29 | $355.60 |
| AVG Volume (30 Days) | 905.6K | ★ 1.2M |
| Earning Date | 11-03-2026 | 10-30-2026 |
| Dividend Yield | N/A | ★ 0.94% |
| EPS Growth | N/A | ★ 44.52 |
| EPS | N/A | ★ 11.08 |
| Revenue | N/A | ★ $2,229,100,000.00 |
| Revenue This Year | $105.39 | N/A |
| Revenue Next Year | $10.19 | $4.63 |
| P/E Ratio | ★ N/A | $32.74 |
| Revenue Growth | N/A | ★ 239.31 |
| 52 Week Low | $282.77 | $227.15 |
| 52 Week High | $482.28 | $371.18 |
| Indicator | WAT | CBOE |
|---|---|---|
| Relative Strength Index (RSI) | 59.22 | 72.13 |
| Support Level | $419.81 | $273.63 |
| Resistance Level | $482.28 | $371.18 |
| Average True Range (ATR) | 16.34 | 13.02 |
| MACD | 0.21 | 2.34 |
| Stochastic Oscillator | 71.57 | 96.58 |
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with Becton Dickinson's life science and diagnostics business, which increased its concentration in diagnostics and discovery-related life science tools.
Founded in 1973, Cboe controls the largest option exchange in the US, which provides around 60% of the firm's revenue. The company is best known for its proprietary S&P 500 and VIX index options, which it offers through an exclusive contract with S&P Global. The firm moved into US and European equities through the $3.4 billion acquisition of BATS in 2017. Cboe has continued to look to expand internationally, using acquisitions to build a presence in both Canada and Australia.